Superbugs are a “second punch” after pandemic

Eileen Drage O'Reilly

September 9, 2022

Superbugs are strengthening their foothold: The COVID-19 pandemic spurred a 15% increase in hospital-related infections and deaths in 2020, per the CDC.

Why it matters: The U.S. was already reporting an antimicrobial resistant (AMR) infection every 11 seconds, and a death from them every 15 minutes before the pandemic. Low- and middle-income countries face worse conditions…

Read the full story on Axios here.

Wall Street Journal

The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably.

The push for antibiotics to fight fast-evolving superbugs is snagging on a broken business model. Six startups have won Food and Drug…

Fighting AMR with a value and subscription model

The recent reintroduction of the Pasteur Bill seeks to address the global threat that antimicrobial-resistant (AMR) infections pose, one subscription…

Scientists use AI to find new antibiotics, but can they climb out of the ‘valley of death’ to the clinic?

Developing a new antibiotic can take as long as 15 years. But in as few as two, the target bug…

‘The Last of Us’ might be fiction, but fungi are a looming threat

Fungal infections are a growing challenge for hospitalized patients, and new treatments are badly needed. A patient with leukemia undergoes…

Name
First Last
Email
Zipcode
Organization
Title
Email
This field is for validation purposes and should be left unchanged.

Axios

Superbugs are a “second punch” after pandemic

Eileen Drage O'Reilly

September 9, 2022

More

Wall Street Journal

The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably.

Pharmaceutical Technology

Fighting AMR with a value and subscription model

Fierce Biotech

Scientists use AI to find new antibiotics, but can they climb out of the ‘valley of death’ to the clinic?

PHARMAVOICE

‘The Last of Us’ might be fiction, but fungi are a looming threat

Sign up for the latest on fighting AMR